Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence
The cellular composition of recurrent tumors can provide insight into resistance to therapy and inform on second line therapies. Here, using a genetically modified mouse, the authors perform barcoding experiments of the primary tumors to allow them to study the clonal dynamics of tumor recurrence.
Main Authors: | Andrea Walens, Jiaxing Lin, Jeffrey S. Damrauer, Brock McKinney, Ryan Lupo, Rachel Newcomb, Douglas B. Fox, Nathaniel W. Mabe, Jeremy Gresham, Zhecheng Sheng, Alexander B. Sibley, Tristan De Buysscher, Hemant Kelkar, Piotr A. Mieczkowski, Kouros Owzar, James V. Alvarez |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-10-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-18730-z |
Similar Items
-
fastJT: An R package for robust and efficient feature selection for machine learning and genome-wide association studies
by: Jiaxing Lin, et al.
Published: (2019-06-01) -
Next Generation Distributed Computing for Cancer Research
by: Pankaj Agarwal, et al.
Published: (2015-04-01) -
Next Generation Distributed Computing for Cancer Research
by: Pankaj Agarwal, et al.
Published: (2014-01-01) -
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
by: Andrea Walens, et al.
Published: (2019-04-01) -
Context-dependent effects of whole-genome duplication during mammary tumor recurrence
by: Rachel Newcomb, et al.
Published: (2021-07-01)